肺栓塞预防和治疗:什么是正确的,什么是错误的,以及未来的未来
Bruce L Davidson1, Nicolas De Schryver2
1Pulmonary and Critical Care Medicine, Washington State University Elson Floyd College of Medicine, Spokane, WA 99202, USA.
Chinese medical journal pulmonary and critical care medicine
|April 14, 2025
概括
目前的肺栓塞 (PE) 预防和治疗存在重大缺陷. 优化低分子量肝素剂量和使用静脉注射抗凝剂治疗急性PE可以改善患者的治疗结果并降低风险.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 有效的肺栓塞 (PE) 治疗和预防对于住院护理至关重要.
- 目前急性PE的药物治疗和预防在过去十年中发生的变化很小.
- 新出现的信息凸显了当前PE管理实践中的重大赤字.
研究的目的:
- 识别和解决当前肺栓塞预防和治疗中的关键缺陷.
- 改善患者的治疗结果,降低与肺栓塞相关的死亡率.
- 根据最近的药理见解和新兴治疗方法指导更新的临床实践.
主要方法:
- 对未分离的肝素和低分子量肝素的早期药理学研究的综述.
- 对低分子量肝素预防和急性PE治疗当前实践的分析.
- 评估新兴治疗方法,包括静脉注射低分子量肝素,吸血栓切除术,导管导向溶解,XI/XIa因子抑制和α-2-抗胺抑制剂.
主要成果:
- 目前每天一次的低分子量肝素预防可能具有低于最佳的生物利用性.
- 在急性PE患者中,皮下抗凝剂的低最佳生物可用性导致治疗不足和复发性血栓栓塞.
- 建议静脉输入抗凝剂作为急性PE的优质初始治疗方法,直到达到血液动力学稳定.
结论:
- 建议通过基于体重的,每天两次或连续输液剂量优化低分子量肝素预防.
- 在急性PE治疗中应迅速采用静脉注射抗凝药,以确保治疗水平并防止复发.
- 对新型治疗方法的进一步研究,如XI/XIa因子抑制和修改的疗法是有必要的.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...